CRISPR-based rapid and ultra-sensitive diagnostic test for Mycobacterium tuberculosis

References

• Organization WH. Global Tuberculosis Report 2017. World Health Organization; 2018.
   Google Scholar
• WHO. Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system. Department/Division; 2011.
   Google Scholar
• Walzl G, McNerney R, du Plessis N, et al. Tuberculosis: advances and challenges in development of new diagnostics and biomarkers. Lancet Infect Dis. 2018;18(7):e199–e210. doi: 10.1016/S1473-3099(18)30111-7
   PubMed Web of Science ®Google Scholar
• Barrangou R, Marraffini LA. CRISPR-Cas systems: prokaryotes upgrade to adaptive immunity. Mol Cell. 2014;54(2):234–244. doi: 10.1016/j.molcel.2014.03.011
   PubMed Web of Science ®Google Scholar
• Marraffini LA, Sontheimer EJ. CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nat Rev Genet. 2010;11(3):181. doi: 10.1038/nrg2749
   PubMed Web of Science ®Google Scholar
• Jinek M, Chylinski K, Fonfara I, et al. A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816–821. doi: 10.1126/science.1225829
   PubMed Web of Science ®Google Scholar
• Koonin EV, Makarova KS. CRISPR-Cas: evolution of an RNA-based adaptive immunity system in prokaryotes. RNA Biol. 2013;10(5):679–686. doi: 10.4161/rna.24022
   PubMed Web of Science ®Google Scholar
• Wu Y, Liang D, Wang Y, et al. Correction of a genetic disease in mouse via use of CRISPR-Cas9. Cell Stem Cell. 2013;13(6):659–662. doi: 10.1016/j.stem.2013.10.016
   PubMed Web of Science ®Google Scholar
• Chen JS, Ma E, Harrington LB, et al. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science. 2018; 360(6387):436–439. doi: 10.1126/science.aar6245
   PubMed Web of Science ®Google Scholar
• Abudayyeh OO, Gootenberg JS, Konermann S, et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science. 2016;353(6299):f5573. doi: 10.1126/science.aaf5573
   Web of Science ®Google Scholar
• Harrington LB, Burstein D, Chen JS, et al. Programmed DNA destruction by miniature CRISPR-Cas14 enzymes. Science. 2018;362(6416):839–842. doi: 10.1126/science.aav4294
   PubMed Web of Science ®Google Scholar
• Liu Y, Xu H, Liu C, et al. CRISPR-Cas13a Nanomachine based simple technology for Avian Influenza A (H7N9) Virus On-Site detection. J Biomed Nanotechnol. 2019;15(4):790–798. doi: 10.1166/jbn.2019.2742
   PubMed Web of Science ®Google Scholar
• Patterson JL, Griffiths A, He Q, et al. Rapid and fully microfluidic ebola virus detection with CRISPR-Cas13a.
   Google Scholar
• Wu Y, Liu S, Wang F, et al. Room Temperature detection of Plasma Epstein–barr Virus DNA with CRISPR–Cas13. Clin Chem. 2019;65(4):591–592. doi: 10.1373/clinchem.2018.299347
   PubMed Web of Science ®Google Scholar
• Association CM. China clinical treatment Guide for tuberculosis. Beijing: People's Medical Publishing House; 2005.
   Google Scholar
• Tessema B, Nabeta P, Valli E, et al. FIND tuberculosis strain Bank: a Resource for Researchers and Developers Working on tests To detect Mycobacterium tuberculosis and related drug resistance. J Clin Microbiol. 2017;55(4):JCM.01662–16. doi: 10.1128/JCM.01662-16
   Web of Science ®Google Scholar
• Zheng H, Lu L, Wang B, et al. Genetic basis of virulence attenuation revealed by comparative genomic analysis of Mycobacterium tuberculosis strain H37Ra versus H37Rv. PLoS ONE. 2008;3(6):e2375. doi: 10.1371/journal.pone.0002375
   PubMed Web of Science ®Google Scholar
• Brisson-Noel A, Nguyen S, Aznar C, et al. Diagnosis of tuberculosis by DNA amplification in clinical practice evaluation. Lancet. 1991;338(8763):364–366. doi: 10.1016/0140-6736(91)90492-8
   PubMed Web of Science ®Google Scholar
• Boyle DS, McNerney R, Low HT, et al. Rapid detection of Mycobacterium tuberculosis by recombinase polymerase amplification. PLoS ONE. 2014;9(8):e103091. doi: 10.1371/journal.pone.0103091
   PubMed Web of Science ®Google Scholar
• Dorman SE, Schumacher SG, Alland D, et al. Xpert MTB/RIF ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis. 2018;18(1):76–84. doi: 10.1016/S1473-3099(17)30691-6
   PubMed Web of Science ®Google Scholar
• WHO. Policy update: Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children, Department/Division; 2013.
   Google Scholar
• Walzl G, McNerney R, du Plessis N, et al. Tuberculosis: advances and challenges in development of new diagnostics and biomarkers. Lancet Infect Dis. 2018;18(7):e199–e210. doi: 10.1016/S1473-3099(18)30111-7
   PubMed Web of Science ®Google Scholar